143 related articles for article (PubMed ID: 34371147)
1. Impact of surfactant selection and incorporation on in situ nanoparticle formation from amorphous solid dispersions.
Yen CW; Kuhn R; Hu C; Zhang W; Chiang PC; Chen JZ; Hau J; Estevez A; Nagapudi K; Leung DH
Int J Pharm; 2021 Sep; 607():120980. PubMed ID: 34371147
[TBL] [Abstract][Full Text] [Related]
2. Design of Redispersible High-Drug-Load Amorphous Formulations: Impact of Ionic
Yu M; Oberoi HS; Purohit HS; Fowler CA; Law D
Mol Pharm; 2023 Nov; 20(11):5827-5841. PubMed ID: 37876176
[TBL] [Abstract][Full Text] [Related]
3. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
Baghel S; Cathcart H; O'Reilly NJ
Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of Dissolution-Induced Nanoparticle Formation from a Copovidone-Based Amorphous Solid Dispersion.
Harmon P; Galipeau K; Xu W; Brown C; Wuelfing WP
Mol Pharm; 2016 May; 13(5):1467-81. PubMed ID: 27019407
[TBL] [Abstract][Full Text] [Related]
5. Impact of surfactants on the crystallization of aqueous suspensions of celecoxib amorphous solid dispersion spray dried particles.
Chen J; Ormes JD; Higgins JD; Taylor LS
Mol Pharm; 2015 Feb; 12(2):533-41. PubMed ID: 25569461
[TBL] [Abstract][Full Text] [Related]
6. Phase separation in surfactant-containing amorphous solid dispersions: Orthogonal analytical methods to probe the effects of surfactants on morphology and phase composition.
Yang R; Zhang GGZ; Kjoller K; Dillon E; Purohit HS; Taylor LS
Int J Pharm; 2022 May; 619():121708. PubMed ID: 35364219
[TBL] [Abstract][Full Text] [Related]
7. Hybrid nanocrystal-amorphous solid dispersions (HyNASDs) as alternative to ASDs for enhanced release of BCS Class II drugs.
Rahman M; Arevalo F; Coelho A; Bilgili E
Eur J Pharm Biopharm; 2019 Dec; 145():12-26. PubMed ID: 31622652
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic insights into effect of surfactants on oral bioavailability of amorphous solid dispersions.
Schittny A; Philipp-Bauer S; Detampel P; Huwyler J; Puchkov M
J Control Release; 2020 Apr; 320():214-225. PubMed ID: 31978445
[TBL] [Abstract][Full Text] [Related]
9. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.
Chavan RB; Lodagekar A; Yadav B; Shastri NR
Drug Deliv Transl Res; 2020 Aug; 10(4):903-918. PubMed ID: 32378174
[TBL] [Abstract][Full Text] [Related]
10. Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.
Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
Mol Pharm; 2016 Aug; 13(8):2787-95. PubMed ID: 27337060
[TBL] [Abstract][Full Text] [Related]
11. Cryo-TEM and AFM Observation of the Time-Dependent Evolution of Amorphous Probucol Nanoparticles Formed by the Aqueous Dispersion of Ternary Solid Dispersions.
Zhao Z; Katai H; Higashi K; Ueda K; Kawakami K; Moribe K
Mol Pharm; 2019 May; 16(5):2184-2198. PubMed ID: 30925218
[TBL] [Abstract][Full Text] [Related]
12. Investigation of novel supersaturating drug delivery systems of chlorthalidone: The use of polymer-surfactant complex as an effective carrier in solid dispersions.
França MT; Nicolay Pereira R; Klüppel Riekes M; Munari Oliveira Pinto J; Stulzer HK
Eur J Pharm Sci; 2018 Jan; 111():142-152. PubMed ID: 28964949
[TBL] [Abstract][Full Text] [Related]
13. Role of Surfactants on Release Performance of Amorphous Solid Dispersions of Ritonavir and Copovidone.
Indulkar AS; Lou X; Zhang GGZ; Taylor LS
Pharm Res; 2022 Feb; 39(2):381-397. PubMed ID: 35169959
[TBL] [Abstract][Full Text] [Related]
14. Development of an Amorphous Solid Dispersion Formulation for Mitigating Mechanical Instability of Crystalline Form and Improving Bioavailability for Early Phase Clinical Studies.
Chiang CW; Lubach JW; Chen T; Chin S; Ly J; Zhang W; Hou HH; Nagapudi K
Mol Pharm; 2023 May; 20(5):2452-2464. PubMed ID: 37010134
[TBL] [Abstract][Full Text] [Related]
15. Stabilizing ability of surfactant on physicochemical properties of drug nanoparticles generated from solid dispersions.
Thongnopkoon T; Puttipipatkhachorn S
Drug Dev Ind Pharm; 2017 Jul; 43(7):1082-1092. PubMed ID: 28161991
[TBL] [Abstract][Full Text] [Related]
16. Impact of Surfactants on the Performance of Clopidogrel-Copovidone Amorphous Solid Dispersions: Increased Drug Loading and Stabilization of Nanodroplets.
Correa Soto CE; Gao Y; Indulkar AS; Ueda K; Zhang GGZ; Taylor LS
Pharm Res; 2022 Jan; 39(1):167-188. PubMed ID: 35013849
[TBL] [Abstract][Full Text] [Related]
17. Spray-Dried Amorphous Solid Dispersions of Atorvastatin Calcium for Improved Supersaturation and Oral Bioavailability.
Kwon J; Giri BR; Song ES; Bae J; Lee J; Kim DW
Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31500147
[TBL] [Abstract][Full Text] [Related]
18. Maintaining Supersaturation of Nimodipine by PVP with or without the Presence of Sodium Lauryl Sulfate and Sodium Taurocholate.
Pui Y; Chen Y; Chen H; Wang S; Liu C; Tonnis W; Chen L; Serno P; Bracht S; Qian F
Mol Pharm; 2018 Jul; 15(7):2754-2763. PubMed ID: 29782805
[TBL] [Abstract][Full Text] [Related]
19. Partitioning of surfactant into drug-rich nanodroplets and its impact on drug thermodynamic activity and droplet size.
Ueda K; Taylor LS
J Control Release; 2021 Feb; 330():229-243. PubMed ID: 33340567
[TBL] [Abstract][Full Text] [Related]
20. Effect of Amorphous Nanoparticle Size on Bioavailability of Anacetrapib in Dogs.
Kesisoglou F; Wang M; Galipeau K; Harmon P; Okoh G; Xu W
J Pharm Sci; 2019 Sep; 108(9):2917-2925. PubMed ID: 30980857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
